Loading organizations...
Key people at Population Health Partners.
Population Health Partners is an investment firm, integrating venture capital and private equity to build and scale companies. It focuses on life sciences, deploying capital and expertise toward innovative therapeutics. The firm identifies and supports technologies designed to transform health outcomes for broad populations.
Established in May 2020, Population Health Partners was founded by Clive Meanwell, M.D., M.B., Ch.B., and Christopher Cox. Dr. Meanwell, a seasoned biopharmaceutical leader from The Medicines Company, partnered with Cox, a Managing Partner. Their insight sought to generate strong financial returns and profound advancements in global health via targeted investments in breakthrough medicines.
Population Health Partners acts as a strategic capital partner for emerging life science companies, providing funding and guidance for therapeutic innovations. Its vision is to extend global health spans and secure strong financial returns. The firm fosters transformative medical solutions, creating lasting value by addressing critical unmet needs.
Key people at Population Health Partners.
Population Health Partners has 4 tracked investments across 3 companies. The latest tracked deal is $75.0M Series A in Areteia Therapeutics in February 2024.